Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1982-12-30
1985-07-16
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 88, 436536, 436538, 436543, A61K 4900, G01N 3348, G01N 3354
Patent
active
045295824
ABSTRACT:
Group C streptococcal antibody levels in a serum sample can be determined via passive protection test in susceptible animals. Test is based on property of protective antibody in the serum sample to reduce the virulence of a group C streptococcal challenge and provides a means for detecting whether an animal (e.g. horse) is susceptible to infection by group C streptococcal organism.
REFERENCES:
patent: 3940475 (1976-02-01), Gross
patent: 4277437 (1981-07-01), Maggio
Bisno, Infec. Immun., 26 (1979), 1172-6.
Peterson et al., J. Infect. Dis., 139 (1979), 575-585.
Fischetti et al., J. Exp. Med., 144 (1976), 32-51.
Lancefield, J. Exp. Med., 67 (1938), 25-40.
Lancefield, J. Exp. Med., 106 (1957), 525-544.
Brown Karen K.
Bryant Sharon A.
Giblin James A.
Miles Laboratories Inc.
Nucker Christine M.
LandOfFree
Titration of group C streptococcal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Titration of group C streptococcal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Titration of group C streptococcal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1735555